Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A nucleic acid aptamer targeting metastatic human breast cancer cells and its application

A technology of human breast cancer cells and metastatic breast cancer, applied in the field of biomedicine, to achieve the effect of obvious metastasis specificity, high specificity and good plasma stability

Active Publication Date: 2022-05-06
中国医科大学
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is no report on the screening of metastatic human breast cancer cell-specific nucleic acid aptamers using metastatic breast cancer cells as target cells and non-metastatic breast cancer cells as non-target cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A nucleic acid aptamer targeting metastatic human breast cancer cells and its application
  • A nucleic acid aptamer targeting metastatic human breast cancer cells and its application
  • A nucleic acid aptamer targeting metastatic human breast cancer cells and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Example 1 The specific binding of the nucleic acid aptamer to the target cell MDA-MB-231 was detected by flow cytometry.

[0023] Human breast cancer cells MDA-MB-231 and MCF-7 in the logarithmic growth phase were respectively digested with enzyme-free digestion solution and blown into a single cell suspension, centrifuged at 1000rpm for 5min to remove the supernatant, and pre-cooled at 4°C Wash cells twice with Wash Buffer. Then add 200 μl of binding buffer containing 250 nM nucleic acid aptamer, incubate gently on a shaker at 4 °C for 30 min, centrifuge at 1000 rpm for 5 min, remove the supernatant, and wash the cells twice with 4 °C pre-cooled washing buffer. Finally, 300 µl PBS was added for flow cytometry detection, and the random library sequence was used as a control.

[0024] The flow cytometry detection results of the nucleic acid aptamer and the target cell MDA-MB-231 and the counter-screened cell MCF-7 are as follows: figure 1 As shown, the nucleic acid apt...

Embodiment 2

[0025] Example 2 Fluorescence microscopy was used to analyze the specific binding of the nucleic acid aptamer to the target cell MDA-MB-231.

[0026] Human breast cancer cells MDA-MB-231 and MCF-7 were cultured in confocal culture dishes respectively. After culturing for 24 hours, aspirate all the liquid in the culture dish, wash twice with 4°C pre-cooled washing buffer, and then combine the binding buffer containing 250nM biotin-labeled nucleic acid aptamer with the above two kinds of cells at 4°C Incubate with gentle shaking for 30min. After incubation, aspirate all the liquid in the culture dish, wash twice with 4°C pre-cooled washing buffer, then add quantum dot-labeled streptavidin QD-SA, and incubate at room temperature for 15 min. After incubation, aspirate all the liquid in the culture dish, wash twice with 4°C pre-cooled washing buffer, and finally add 300 µl PBS for detection, random library sequence as a control, the results are as follows figure 2 shown.

[002...

Embodiment 3

[0028] Example 3 The dissociation constant of the nucleic acid aptamer to the target cell MDA-MB-231 was determined by flow cytometry.

[0029] The nucleic acid aptamers of different concentrations were synthesized and prepared, incubated with the same amount of target cells respectively, and flow cytometry detection was performed according to the operation of Example 1, and the fluorescence intensity of the target cells under different nucleic acid aptamer concentrations was measured. Take the concentration of the nucleic acid aptamer as the abscissa, and the corresponding fluorescence intensity value as the ordinate, and fit the curve according to the formula Y=BmaxX / (Kd+X) to obtain the dissociation curve of the nucleic acid aptamer, as image 3 shown. The dissociation constant Kd of the nucleic acid aptamer obtained from the dissociation curve was 45.6 ± 1.2 nM.

[0030] The results show that: the nucleic acid aptamer has high affinity binding property to the target cell ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of biomedicine, and relates to a nucleic acid aptamer targeting metastatic human breast cancer cells and an application thereof. The nucleic acid aptamer sequence is 5'-AAGGAGCAGCGTGGAGGATATACACCGTCATCAGAGGGAGCATCTCTAGTCAGGACTGTGATGAATTAGGGTGTGTCGTCGTGGT-3'. The nucleic acid aptamer of the present invention has high specificity, high affinity and good plasma stability, and can maintain good activity at 4°C, 25°C, and 37°C. The nucleic acid aptamer of the present invention can be used as a molecular probe for specific imaging and detection of metastatic breast cancer cells; as a capture probe for specific capture analysis of circulating tumor cells in peripheral blood. It has a good application prospect in the prediction, diagnosis and treatment of breast cancer metastasis.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and relates to a nucleic acid aptamer targeting metastatic human breast cancer cells and an application thereof. Background technique [0002] Breast cancer is a high incidence of malignant tumors in women, and metastasis is the main cause of death in patients. The development of highly sensitive and specific molecular probes is of great significance for accurately predicting the metastasis and recurrence of breast cancer, thereby improving the effectiveness of treatment and improving the survival rate of patients. [0003] Nucleic acid aptamers (aptamers) are screened from large-capacity RNA / single-stranded DNA random libraries using the Systematic Evolution of Ligands by Exponential enrichment (SELEX) technology, which can specifically bind to target substances. Oligonucleotide sequences, known as chemical antibodies. Compared with traditional antibodies, it has the characteristics of str...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/115G01N33/574
CPCG01N33/57415C12N15/115C12N2310/16
Inventor 方瑾李婉明周琳琳
Owner 中国医科大学
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com